Company profile
Deverra Therapeutics
Seeking Remission for All
- Industry
- Biotechnology
- Employees
- 6
- Headquarters
- Seattle
- Founded
- 2020
- Office locations
- 1
Deverra Therapeutics company summary
Deverra Therapeutics is a company in the Biotechnology industry, headquartered in Seattle, founded in 2020. On LinkedIn the company has around 6 employees.
What technology does Deverra Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Deverra Therapeutics
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.
Where is Deverra Therapeutics located?
Deverra Therapeutics lists 1 location.
Compare companies similar to Deverra Therapeutics
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Deverra Therapeutics deverratx.com | Biotechnology | 6 | 2020 | Seattle |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Deverra Therapeutics
What does Deverra Therapeutics do?
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.
How many employees does Deverra Therapeutics have?
Deverra Therapeutics has around 6 employees on LinkedIn.
Where is Deverra Therapeutics headquartered?
Deverra Therapeutics is headquartered in Seattle.
When was Deverra Therapeutics founded?
Deverra Therapeutics was founded in 2020.
Build a lead list from companies like Deverra Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.